INDICE: Contents of the 2nd edition . Introduction: Explanation of the philosophy, structure and ways to use of the book Section 1: Principles of evidenced–based medicine . 1] Searching for evidence. 2] Appraising the literature. 3] Economic evaluation of cancer treatments. 4] Evidence–based approach to diagnostic techniques. 5] Strengths and weaknesses of prognostic and predictive factors in cancer. . Section 2: Cancer prevention . 6] Stopping smoking. 7] Breast cancer. 8] Colorectal cancer. 9] Skin cancer. 10] Cervix cancer. 11] Hepatocellular cancer. 12] Diet and alcohol in cancer prevention. . Section 3: Screening for cancer . 13] breast cancer. 14] cervical cancer. 15 Colorectal cancer. 16] Prostate cancer. 17] Ovarian cancer. 18] Lung cancer. 19] Stomach cancer. 20] Melanoma. Section 4: Management of tumours of the respiratory system . 21] Non–small cell lung cancer. 22] Small cell lung cancer. 23] mesothelioma. Section 5: Management of head and neck cancers . 24] Oral and salivary gland cancers. 25] Nasoparyngeal cancers. 26] Laryngeal cancers. Section 6: Management of tumours of the gastrointestinal system . 27] Oesophageal cancer. 28] Stomach cancer. 29] Pancreatic cancer. 30] Hepatobiliary cancers. 31] Small bowel cancers. 32] Cancer of the colon and rectum. 33] Anal cancer. Section 7: Management of tumours of the urogenital system . 34] Kidney cancer. 35] Bladder cancer. 36] Prostate cancer. 37] Penile cancer. 38] Testicular Germ cell cancer. Section 8: Management of tumours of the female reproductive system. 39] Ovarian, primary peritoneal and fallopian tube cancers. 40] Cancer of the endometrium. 41] Cancer of the cervix. 42] Cancer of the vagina. 43] Cancer of the vulva. 44] Ovarian germ cell tumours. 45] Gestational trophoblastic tumours. 46] Uterine sarcomas. Section 9: Management of breast cancer. 47] Early breast cancer. 48] Advanced or recurrent breast cancer. Section 10: Management of skin cancer. 49] Cutaneous melanoma. 50] Basal cell cancer. 51] Squamous cancer of the skin. 52] Kaposi’s sarcoma. Section 11: Management of sarcomas. 53] Soft tissue sarcomas. 54] Bone sarcomas. Section 12: Management of central nervous system cancers. 55] Central nervous system tumours. Section 13: Management of tumours of the eye and associated structures. 56] Uveal melanoma. 57] Orbital and adnexal tumours. . Section 14: Management of the elderly and those with co–morbid conditions . 58] Evidence on adjusting treatment of cancer to take into account co–morbidity. Section 15: Palliative management of cancer. 59] Assessing the needs of cancer patients. 60] Managing pain from cancer. 61] Managing other common symptoms of cancer. Section 16: Managing complications of cancer and its treatment. 62] Managing neutropenia, sepsis and thrombocytopenia. 63] Managing venous thrombosis and pulmonary embolism. 64] Serous effusions. 65] Metabolic complications. 66] Disseminated intravascular coagulation. 67] Spinal metastatic disease and pathological fractures. . . Section 17: Assessing the evidence for new treatments under development . 68] Vaccines for cancer. 69] Small molecules and targeted therapies. 70] New cytotoxic agents. 71] Hadron radiotherapy. 72] Scheduling and techniques used to deliver higher radiation doses Section 18: Complementary and alternative treatments for cancer. 73] Evidence–based assessment of CAM treatments. Section 19: Assessing how is cancer care best delivered. 74] Optimising delivery of cancer care. Section 20: Aids in delivering evidence–based care. 75] Essential materials for helping deliver care and sources of addition support
- ISBN: 978-1-4051-6003-2
- Editorial: Wiley–Blackwell
- Encuadernacion: Cartoné
- Páginas: 760
- Fecha Publicación: 09/02/2015
- Nº Volúmenes: 1
- Idioma: Inglés